These stocks are currently highlighted by analysts for having significant upside potential relative to their low entry price:
: Priced at $4.03, this biotech stock has a low forward P/E of 3.00 and projected sales growth of over 103%. cheap stocks to buy today
: Trading at $292.07, it is noted for efficient cash production and a free cash flow yield that outperforms major healthcare competitors. These stocks are currently highlighted by analysts for